Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MindBio Therapeutics Corp C.MBIO

MindBio Therapeutics Corp. is a biotech/biopharma company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its... see more

CSE:MBIO - Post Discussion

MindBio Therapeutics Corp > Why Would Enveric Do This?
View:
Post by Smokey1958 on May 14, 2024 10:03am

Why Would Enveric Do This?

The potential in this is extraordinary for both companies.

I would expect that the reasons for Enteric entering into an agreement like this is that they have a much faster path to clinical trials for their patented drugs and system. By the time they could get FDA approval MBIO could be on to the second phase of trials.

As for MBIO the most significant challenge would be cash to carry out trials for a different drug candidate. The fact that they're expressing payback through royalties etc in the $60+ million range suggests there is strong belief in the relationship.

As for the cash buyout ...does it refer to the potential for MBIO to ultimately buy out Enteric? It looks to me like Justin and the rest of the Board of MBIO has their hands solidly on the wheel.

Regardless, this is the kind of exponential development seen in this clinical trials stage of MBIO.
Comment by Smokey1958 on May 14, 2024 11:34am
This may be the "link" to MBIO I suggested in the first post. According to the Enveric website their next step for this particular formulation was in looking to do an FIH (first in human trial) in Australia. What better way to accomplish this then through a collaboration with an existing company (MBIO) that has already achieved several regulatory approvals for this type of research. As ...more